Campaign.ConstantContact.com – NCTE
In a closely-watched case, the United States Tax Court overwhelmingly ruled on Tuesday in O’Donnabhain v. Commissioner of Internal Revenue that a transgender woman’s medical expenses for hormone therapy and sex reassignment surgery were medically necessary and therefore tax-deductible under Federal law. After considering extensive medical evidence and testimony from leading medical experts, the court rejected an interpretation of the law that would consider transgender people’s medical treatment different than all other medically necessary treatment recommended by major medical and psychological organizations.